CA2213842C - Utilisation de dextromethorphane ou de dextrorpharne pour le traitement de l'incontinence urinaire - Google Patents

Utilisation de dextromethorphane ou de dextrorpharne pour le traitement de l'incontinence urinaire Download PDF

Info

Publication number
CA2213842C
CA2213842C CA002213842A CA2213842A CA2213842C CA 2213842 C CA2213842 C CA 2213842C CA 002213842 A CA002213842 A CA 002213842A CA 2213842 A CA2213842 A CA 2213842A CA 2213842 C CA2213842 C CA 2213842C
Authority
CA
Canada
Prior art keywords
morphinan
pharmaceutically acceptable
dextromethorphan
group
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002213842A
Other languages
English (en)
Other versions
CA2213842A1 (fr
Inventor
Frank S. Caruso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Endo Pharmaceuticals Inc
Original Assignee
Algos Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Algos Pharmaceutical Corp filed Critical Algos Pharmaceutical Corp
Priority claimed from PCT/US1996/002809 external-priority patent/WO1996027375A2/fr
Publication of CA2213842A1 publication Critical patent/CA2213842A1/fr
Application granted granted Critical
Publication of CA2213842C publication Critical patent/CA2213842C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

On peut atténuer l'incontinence urinaire chez un mammifère par l'administration au sujet d'une dose efficace de dextrométhorphane, dextrorpharne, leurs mélanges et/ou leurs sels pharmaceutiquement acceptables, seuls ou en association avec un agent pharmacologiquement actif tel qu'un composé anticholinergique, sympathomimétique, antidépresseur tricyclique, antispasmodique, relaxant direct des muscles souples, oestrogène, à effet oestrogénique, ou toute combinaison de ces substances.
CA002213842A 1995-03-03 1996-03-01 Utilisation de dextromethorphane ou de dextrorpharne pour le traitement de l'incontinence urinaire Expired - Fee Related CA2213842C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39838995A 1995-03-03 1995-03-03
US08/398,389 1995-03-03
PCT/US1996/002809 WO1996027375A2 (fr) 1995-03-03 1996-03-01 Utilisation de dextromethorphane ou de dextrorpharne pour le traitement de l'incontinence urinaire

Publications (2)

Publication Number Publication Date
CA2213842A1 CA2213842A1 (fr) 1996-09-12
CA2213842C true CA2213842C (fr) 2006-10-03

Family

ID=37101760

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002213842A Expired - Fee Related CA2213842C (fr) 1995-03-03 1996-03-01 Utilisation de dextromethorphane ou de dextrorpharne pour le traitement de l'incontinence urinaire

Country Status (1)

Country Link
CA (1) CA2213842C (fr)

Also Published As

Publication number Publication date
CA2213842A1 (fr) 1996-09-12

Similar Documents

Publication Publication Date Title
EP0820288B1 (fr) Utilisation de dextromethorphane ou de dextrorphane pour le traitement de l'incontinence urinaire
EP1933833B1 (fr) Therapie pour le traitement de la vessie hyperactive
US5939426A (en) Methods for treating urinary incontinence using descarboethoxyloratadine
CA2001996C (fr) Methode de traitement de la cystite interstitielle
Arai et al. Use of nicardipine in the anesthetic management of pheochromocytoma
WO2012154779A1 (fr) Associaitons d'oxybutynine et de stimulants salivaires pour le traitement d'une vessie hyperactive
US20020183291A1 (en) Product for treating gynecomastia
EP2706997B1 (fr) Combinaisons de solifénacine et pilocarpine pour le traitement d'une vessie hyperactive
US4181726A (en) Method of alleviating pruritis
CA2213842C (fr) Utilisation de dextromethorphane ou de dextrorpharne pour le traitement de l'incontinence urinaire
US6949548B2 (en) Combination therapy for the treatment of heart failure
US5145851A (en) Method for treating urinary obstruction
Niarchos et al. Role of renin and aldosterone suppression in the antihypertensive mechanism of clonidine
US20120289547A1 (en) Combinations of propiverine and salivary stimulants for the treatment of overactive bladder
US3108041A (en) Antitussive compositions
CA1110170A (fr) Composes hypotenseurs
SG194807A1 (en) Combinations of trospium and salivary stimulants for the treatment of overactive bladder
EP1581227A1 (fr) Procede pour traiter l'insuffisance renale
JPH0576925B2 (fr)
EP0125508A1 (fr) Procédé pour la stabilisation d'un muscle détruseur tout en augmentant la force de ce muscle détruseur
Morita et al. P-674: Amlodipine reduces arterial stiffness through improvements of vascular collagen metabolism in patients with essential hypertension
Kario et al. P-672: The Japan Morning Surge-1 (JMS-1) Study: A multicenter randomized trial to study effect of strict morning blood pressure control on target organ damage in morning hypertension
US20120289567A1 (en) Combinations of darifenacin and salivary stimulants for the treatment of overactive bladder
Majmudar et al. Current drug treatments for female urinary incontinence
WO1990007927A1 (fr) Agent de traitement de l'hypertrophie de la prostate

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20150302

MKLA Lapsed

Effective date: 20150302